RAPT Therapeutics to Engage Investors in Upcoming Conferences
RAPT Therapeutics, Inc. (NASDAQ: RAPT), an innovative biopharmaceutical company based in South San Francisco, is gearing up for a series of influential investor conferences this March. The company's focus on developing cutting-edge therapies for immunological conditions positions them at the forefront of healthcare innovation, making their participation in these events highly anticipated.
Details of Upcoming Conferences
The management team at RAPT Therapeutics is scheduled to participate in the following key events:
- Leerink Global Healthcare Conference – The first event will feature an engaging fireside chat on March 11, providing insights into RAPT's strategic initiatives at 3:40 p.m. ET.
- Barclays 27th Annual Global Healthcare Conference – Following closely, on March 12, RAPT representatives will also host a fireside chat at 10:30 a.m. ET, elaborating on their potential and future projects.
These platforms not only highlight RAPT's innovative work but also facilitate dynamic conversations with potential investors and industry professionals.
Accessing Discussions
To engage with these discussions live or to access archived versions later, interested parties are encouraged to visit the RAPT Therapeutics website. These webcasts are crucial for stakeholders wanting a deeper understanding of RAPT’s direction and initiatives.
About RAPT Therapeutics
RAPT Therapeutics is dedicated to pioneering therapies for patients affected by inflammatory and immunological disorders. Leveraging extensive expertise in immunology, the company develops novel approaches aimed at modulating the immune responses integral to managing these conditions. Their commitment to transforming patient care through innovative solutions underscores their position in the biopharmaceutical landscape.
Contact Information for Investors and Media
Investors interested in inquiries can reach out to:
Sylvia Wheeler
Email: swheeler@wheelhouselsa.com
For media-related inquiries, contacts are as follows:
Aljanae Reynolds
Email: areynolds@wheelhouselsa.com
Frequently Asked Questions
What type of company is RAPT Therapeutics?
RAPT Therapeutics is a clinical-stage biopharmaceutical firm focused on developing therapies for inflammatory and immunological diseases.
When is RAPT participating in the investor conferences?
RAPT's management will present at the Leerink Global Healthcare Conference on March 11 and the Barclays Global Healthcare Conference on March 12.
Where can I watch the RAPT webcasts?
The live webcasts and recorded sessions can be found on the RAPT Therapeutics official website following the conferences.
Who do I contact for investor relations?
For investor inquiries, you can contact Sylvia Wheeler via email at swheeler@wheelhouselsa.com.
How does RAPT Therapeutics contribute to healthcare?
RAPT Therapeutics focuses on developing innovative therapies aimed at modulating immune responses to improve treatment for patients suffering from chronic inflammatory and immunological conditions.